Monoclonal antibody RM2 as a potential ligand for a new immunotracer for prostate cancer imaging.

研究業績

詳細

Monoclonal antibody RM2 as a potential ligand for a new immunotracer for prostate cancer imaging. Hasegawa Y, Oyama N, Nagase K, Fujibayashi Y, Furukawa T, Murayama Y, Arai Y, Saito S, Welch MJ, Yokoyama O. Nucl Med Biol. 2012 Oct;39(7):944-7. doi: 10.1016/j.nucmedbio.2012.05.008. Epub 2012 Jul 4. PMID: 22766258